The Clara cell secretory protein (CCSP) imparts a protective effect to the lung during oxidant injury. However, exposure to supplemental oxygen, a common therapeutic modality for lung disease, represses the expression of CCSP in the adult mouse lung. We investigated the mechanisms of hyperoxia-induced repression of the mouse CCSP promoter. Deletion experiments in vivo and in vitro indicated that the hyperoxia-responsive elements are localized to the proximal -166 bp of the CCSP promoter. Electrophoretic mobility shift and supershift analyses demonstrated increased binding of c-Jun at the activator protein-1 site, increased binding of CCAAT/enhancer binding protein (C/EBP) β at the C/EBP sites, and decreased binding at the Nkx2.1 sites. Western analyses revealed that hyperoxia exposure induced an increase in the expression of the C/EBPβ isoform liver-inhibiting protein (LIP) and an increase in cytoplasmic Nkx2.1. Cotransfection of LIP or c-Jun expression plasmids decreased the transcriptional activity of the proximal -166-bp CCSP promoter. These observations suggest that hyperoxia-induced repression of the CCSP gene is mediated, at least in part, at the level of transcription and that multiple mechanisms mediate this repression. Moreover, these novel observations may provide insights for generation of therapeutic interventions for the amelioration of oxidant-induced lung injury.
Initial investigations were designed to identify the location of the hyperoxia-responsive region of the CCSP promoter and, subsequently, to further dissect the interactions of specific cis elements and their cognate trans-acting factors that may mediate the hyperoxia-induced repression of CCSP gene expression. Previous analyses investigating the regulation of other proteins in the lung support the hypothesis that exposure to hyperoxia alters the protein-DNA interactions of specific redox-sensitive transcription factors, such as activator protein-1 (AP-1), thereby altering target gene expression patterns (9) . The 5'-flanking region of the CCSP gene (Fig. 1A) is known to contain an AP-1 consensus sequence in addition to many other key regulatory cis elements (10) (11) (12) (13) . The presence of this complex composite of cis elements suggests the high likelihood of multiple protein-DNA interactions both in the baseline expression of CCSP and in the hyperoxiainduced repression of the CCSP gene.
Historically, the 5'-flanking region of the CCSP gene was delineated as two distinct regulatory regions-the proximal and the distal promoter regions. The proximal region, spanning the initial 166 bp upstream from the start of transcription, is sufficient to drive cell-specific CCSP gene expression (12) (13) (14) and mediates cytokine induction of CCSP (15) . The distal region, spanning the segment from -803 to -166 bp, is vital for driving reporter gene activity to absolute levels comparable to endogenous CCSP expression in vivo (12) . Each region contains multiple cis elements that may serve as binding sites for specific transcription factors (12, (16) (17) (18) .
The trans-acting factors that bind the proximal promoter region and that have been identified with a role in CCSP gene expression in either lung development or cytokine stimulation include AP-1 (10), hepatocyte nuclear factor 3 (HNF-3) (10, 19) , CCAAT/enhancer binding protein (C/EBP) (11) , and thyroid transcription factor 1 (Nkx2.1) (10, 15, 20, 17) . The specific nucleotide sequences for binding these transcription factors are very close to one another; in fact, the specific nucleotide sequences for AP-1, HNF-3, and C/EBP binding overlap (Fig. 1B) . This complex assembly of overlapping nucleotide sequences is further convoluted by the proximity of the Nkx2.1 sites. However, there is a paucity of published reports identifying critical cis elements in the distal promoter that may have a role in CCSP gene expression. To date, the cis elements that have been identified in the distal promoter region include three consensus binding sites for Nkx2.1 and a single interferon γ activation site (12, 19) .
This composite of multipart cis elements in the proximal promoter region, as well as the redundancy of Nkx2.1 sites in the distal promoter region, suggests the potential for interactions and cooperation among transcription factors relevant to CCSP gene regulation. The potential that hyperoxia exposure may elicit a change in the cellular redox status, thereby altering the binding of AP-1 family members, is well recognized for other lung proteins (9) . However, the potential that hyperoxia induces a similar change in AP-1 protein-DNA interactions or the binding of other as yet unidentified redox-sensitive transcription factors to the CCSP promoter is unknown. Thus, we initiated this study to determine the underlying mechanism(s) for hyperoxia-induced repression of the CCSP gene.
MATERIALS AND METHODS

Transgenic mouse analysis
Previously generated transgenic mice that expressed a human growth hormone (hGH) reporter gene driven by an -803-bp or -166-bp segment of the CCSP promoter were used for in vivo assessment of the effects of hyperoxia exposure on endogenous CCSP and CCSP reporter gene expression of hGH (12) . All animals were housed at the Baylor College of Medicine animal facility with a 12:12 light-dark cycle and free access to food and water. All animals received proper care, use, and humane treatment according to standards of the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and Federal Animal Welfare Regulations. In addition, the Baylor College of Medicine institutional review board approved the study. The age-and sex-matched adult transgenic mice (n = 3-5/group) were exposed to 0, 24, 48, or 72 h of >95% oxygen under clear acrylic hoods. CO 2 was removed with soda lime. Animals were monitored twice daily for signs of distress, cage maintenance, and soda lime replacement as needed. After the predetermined exposure time, the mice were killed by lethal injection of Avertin. The tracheas were isolated and cannulated with PE-50 tubing and sutured into place. The right lungs were excised and snap-frozen in liquid nitrogen. The left lungs were infused with 10% buffered formalin under 20 cm of constant pressure, removed, and placed in 10% buffered formalin overnight for 16 h and were subsequently immersed in 70% alcohol.
RNase protection assay
Total RNA was extracted from snap-frozen mouse lungs by using the TRIzol method (Invitrogen, Carlsbad, CA). RNA concentrations were determined by spectrophotometric absorption at 260 nm (Spectronic 601, Milton Roy, Ivyland, PA) and stored at -80°C until further analyses were done. Mouse lung expression of CCSP and hGH mRNA was accomplished by RNase protection assays using 32 P-UTP (ICN) labeled probes and RNase Protection Assay Kits according to the manufacturer's protocol (Ambion, Austin, TX). The template for the CCSP mRNA was generated by insertion of a 327-bp BamHI and Not1 fragment of the mouse CCSP cDNA into a pCRII vector (Invitrogen). Digesting the plasmid with BamHI generated an antisense riboprobe for RNA protection assay (RPA), and T7 RNA polymerase was used for in vitro RNA synthesis. A template for hGH mRNA was generated by inserting a 2.0-kb EcoRI fragment of the hGH cDNA into pBluescript (Stratagene, La Jolla, CA). An antisense riboprobe for RPA was generated by digestion of this plasmid with BglII and by using T7 RNA polymerase for in vitro RNA synthesis. A cyclophilin probe was used as an internal control for all RPAs.
Immunohistochemistry in mouse lung sections
Lung sections collected at the time of tissue harvest were fixed in 10% buffered formalin and cut into 3-µm sections. The sections were dried at 60°C for 1 h. Sections were deparaffinized in three changes of xylene for 5 min each and were subsequently hydrated in descending grades of ethanol and rinsed in water several times. The sections were treated with citrate antigen retrieval for 25 min and cooled for 10 min. Blocking was achieved with 3% H 2 O 2 /methanol for 15 min followed by rinsing in water and then Tris-buffered saline supplemented with 0.1% Tween (TBST) (DAKO, Carpinteria, CA). The sections were incubated with a rabbit polyclonal CCSP primary antibody at a concentration of 1:20,000 (21) or a polyclonal hGH antibody (SigmaAldrich, St. Louis, MO) at a concentration of 1:3000 for 20 min at room temperature, followed by rinsing in TBST. Subsequently, sections were incubated in multilink anti-rabbit antibody (BioGenex, San Ramon, CA) for 10 min at room temperature, followed by rinsing in TBST. AEC (DAKO) was applied, and sections were rinsed in TBST and then water. The sections were counterstained in hematoxylin for 12 s and dipped into Bluing Reagent and then mounted.
Cell culture and transient transfection analyses
The mouse transformed Clara cells (mtCC) (19) were plated at a density of 3 × 10 6 cells per 60-mm plate and grown in Dulbecco's modified Eagle's medium (DMEM, BioWhittaker, Walkersville, MD) supplemented with 10% FBS until the cells were 50-70% confluent. All cells were grown under 5% CO 2 at 37°C. The cells were transiently transfected by using Superfect transfection reagent (QIAGEN, Valencia, CA), according to the manufacturer's protocol. Each well received 2 µg of a CCSP reporter plasmid (15) and 0.5 µg of a Renilla luciferase reporter gene (Luc) as an internal control. The transfected cells were incubated for 3 h, washed with DMEM to remove the transfecting agent, and then fed with DMEM with 10% FCS. The cells were exposed to a mixture of 5% CO 2 and either 21% or 95% oxygen for 24 h and were harvested in 1× reporter lysis buffer (Promega, Madison, WI). The cell lysate was subjected to repetitive freeze-thaw cycles (repeated four times) and then centrifuged at 12,000g in a microcentrifuge for 15 s at room temperature. The supernatant was then removed and the luminescent signals, generated by the firefly and Renilla luciferase reporter genes, were measured by using the dual luciferase reporter assay (Promega) and a Monolight Luminometer (BD Biosciences PharMingen, San Diego, CA).
Whole cell protein extracts
mtCC for protein analyses were plated and grown to 70% confluency, harvested in PBS, centrifuged for 5 min, and resuspended in 100 µl of 250 mM Tris, pH 7.5. Prior to harvesting, the cells were exposed to a mixture of 5% CO 2 and either 21% or 95% oxygen for 6, 12, or 24 h. The cells were lysed by three cycles of freezing in liquid N 2 and thawing at 37°C. Cell debris was cleared by centrifugation, and the protein concentration of the supernatant was measured with Bradford reagent (Bio-Rad Laboratories, Hercules, CA).
Western blot analyses
Samples obtained from whole lung homogenates, mtCC whole cells, or mtCC nuclear extracts were used for Western analyses after the protein content of each sample was determined. Equal amounts of protein (40 µg) from each sample were supplemented with an equal amount of sodium dodecyl sulfate (SDS) loading buffer and boiled for 5 min. The proteins were then separated on 12% SDS-polyacrylamide gels. After electrophoresis, the proteins were transferred from the gel to a polyvinylidene fluoride membrane (Millipore, Bedford, MA) at 4°C. The membranes were then blocked in 5% milk and PBS, followed by incubation overnight with a primary rabbit anti-C/EBPβ antibody (Affinity Bioreagents, Golden, CO, and Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were then washed in PBS for 10 min three times, followed by addition of a secondary goat anti-rabbit antibody (Santa Cruz Biotechnology). The immunoreactive proteins were detected by using a chemiluminescent detection kit according to the manufacturer's protocol (Amersham Pharmacia Biotech UK, Buckinghamshire, UK).
EMSA
EMSA was performed with 10 µg of mtCC nuclear extract from mtCC exposed to either 21% or 95% oxygen and 32 P-labeled oligonucleotides. Further identification of proteins present within the protein-DNA complexes formed between the labeled oligonucleotides and the mtCC nuclear proteins was performed by Supershift analyses. The 32 P-labeled oligonucleotides were generated by using either a 30-bp sequence from the CCSP proximal region spanning the AP-1, HNF-3, and C/EBP consensus binding sites (5'-AGAAGATGACCAAGTAAATAATGCAATCTC-3') with the appropriate mutations allowing for specific binding of AP-1 and C/EBP as described previously (15) or a 23-bp sequence from the proximal promoter region spanning the Nkx2.1 consensus binding site (5'-GCACCTGGAGGGCTCTTCAGAGC-3') using a Sequenase reaction kit (USB, Cleveland, OH). The 32 P-labeled oligonucleotides were then incubated with mtCC nuclear extracts from cells exposed to either 21% or 95% oxygen. The unlabeled oligonucleotides at 10-fold molar excess were used as competitors. EMSA and Supershift analyses were completed to determine the presence of specific trans-acting factors in mtCC nuclear extracts and to optimize conditions for adequate competitive inhibition before hyperoxia exposure investigations (15) . Antibodies, including c-Fos, Fra-1, Fra-2, c-Jun, C/EBPα, C/EBPβ, and C/EBPδ (Santa Cruz Biotechnology, 200 µg/ml), used for Supershift analyses, and a polyclonal rabbit anti-Nkx2.1 antibody raised against recombinant Nkx2.1 were added to the mtCC nuclear extracts before the 32 P-labeled oligonucleotides were added, and then samples were incubated for 15 min at room temperature. Subsequently, the cold competitors and the 32 Plabeled oligonucleotides were added to the nuclear extracts and incubated at room temperature for an additional 20 min. The complexes were separated by electrophoresis through a 6% nondenaturing polyacrylamide gel, dried onto filter paper, and exposed to autoradiographic film. The antibody concentration used in each Supershift assay was determined for each antibody separately (data not shown).
RESULTS
Localization of the hyperoxia-responsive region of the CCSP promoter in vivo
The hyperoxia-responsive region of the CCSP promoter was localized in vivo to the proximal -166-bp region of the CCSP promoter by using transgenic mice previously generated with either the -803-bp or -166-bp fragment of the CCSP promoter ligated to an hGH reporter gene (12) . Immunohistochemistry and RPA were used to demonstrate the effects of hyperoxia exposure on the endogenous expression of CCSP and the reporter gene expression of hGH in these transgenic mice at both protein and mRNA levels. The high endogenous level of CCSP in adult mouse lung exposed to room air ( Fig. 2A) is seen within the dome-shaped nonciliated bronchiolar epithelial cells. This is in contrast to the greatly reduced level of CCSP visible within the bronchiolar epithelial cells in adult mouse lung at 72 h of hyperoxia exposure (Fig. 2B) . The expression patterns of the hGH transgene generated with the -166-bp segment of the CCSP promoter in the adult mouse lung exposed to room air ( The decrease in protein expression induced by hyperoxia exposure for both endogenous CCSP and the reporter hGH correlated with a decrease in the level of mRNA expression for both CCSP and hGH by RPAs. The hyperoxia-induced repression of CCSP and hGH mRNA is shown in Fig. 2I and 2J, respectively; quantification of these results by densitometry is illustrated in Fig.  2K and 2L. These findings illustrate that hyperoxia-induced repression of the CCSP gene is mediated, at least in part, at the level of transcription and that this regulation is localized to the proximal -166-bp segment of the CCSP promoter in vivo.
Localization of the hyperoxia-responsive region of the CCSP promoter in vitro
Transient transfection analyses confirmed the localization of the hyperoxia-responsive region of the CCSP promoter to the proximal -166-bp region in vitro. Two CCSP-Luc gene chimeric constructs generated with either the -803-bp region or the -166-bp region of the CCSP promoter ligated to a luciferase reporter gene were used for transient transfections into mtCC. The transiently transformed mtCC were then exposed to either room air or 95% oxygen for 24 h. The resultant reporter gene activities are given in Fig. 3 . The-803-bp segment of the CCSP gene was able to drive expression of the reporter gene to the highest levels in mtCCs under normoxic conditions. In fact, the -803-bp reporter gene activity under these conditions was about 86% greater than the expression level generated by the -166-bp reporter gene. The expression levels obtained from the -803-bp and -166-bp segments of the CCSP gene were greatly reduced in mtCC exposed to hyperoxia. However, the expression level of the -803-bp reporter gene was reduced by about 40% with hyperoxia exposure, whereas the -166-bp reporter gene was reduced by more than 80% with hyperoxia exposure. The decreased reporter gene activity with the CCSP promoter in the mtCC is in contrast to the demonstrated increase in reporter gene activity generated by the surfactant protein B promoter in response to hyperoxia exposure. These observations support the in vivo findings that both proximal and distal promoter regions are responsive to hyperoxia. However, the proximal promoter region is sufficient to illustrate hyperoxia responsiveness. These results suggest that the cis elements and their trans-acting factors within the proximal promoter mediate, at least in part, the hyperoxia-induced repression of CCSP. Moreover, these results suggest that the hyperoxia-induced repression of CCSP is mediated at the level of transcription and that the hyperoxia-induced alterations in lung proteins are gene specific.
Effects of hyperoxia exposure on AP-1 binding to the CCSP promoter
There is evidence that the AP-1 family of transcription factors plays an important role in the regulation of target genes involved in adaptive responses to oxidative stress (9) . Previous investigations of nuclear proteins obtained from mtCC exposed to room air have shown minimal protein binding to the AP-1 consensus site (15) . This binding level was seen again in the EMSA in Fig. 4A , lane 2: the protein-DNA complex formed between nuclear proteins obtained from mtCC exposed to room air and a labeled AP-1 probe is minimally visible, in stark contrast to the protein-DNA complex formed when nuclear extracts were obtained from mtCC exposed to hyperoxia, shown in lane 3. Therefore, to determine the specificity of AP-1 binding and the identity of individual AP-1 family members present within the protein-DNA complex formed in response to hyperoxia exposure, the remaining lanes (4-10) were loaded with nuclear extracts from mtCC exposed to hyperoxia, and competetion and supershift analyses were conducted. The specificity of the protein-DNA complex formed with the AP-1 nucleotide sequence was confirmed with the addition of unlabeled oligonucleotides in lane 4, which shows the slower migrating band was reduced in intensity, and in lane 5, which shows that the addition of nonspecific unlabeled oligonucleotides failed to reduce the intensity of the band by competition. Antibodies for specific AP-1 family members that are known to form homodimers or heterodimers and bind the AP-1 site were added (lanes 6-9) to determine whether any of these proteins were present in the protein-DNA complex. The supershift in Fig. 4A, lane 9 , reveals that the protein c-Jun was contained in this protein-DNA complex. The effect of c-Jun on the activity of the proximal -166-bp CCSP promoter was determined in vitro by transient cotransfection of the 166 CCSP-Luc reporter gene constructs with c-Jun expression plasmids and vector-only DNA constructs to maintain equal amounts of DNA per well. The observed dose-dependent decrease in CCSP expression (Fig. 4B) suggests that c-Jun acted to reduce the expression of the CCSP gene.
Effects of hyperoxia exposure on C/EBP binding to the CCSP promoter
The C/EBP sites in the proximal CCSP promoter are essential and function cooperatively to drive CCSP expression (11) . The proximity of the C/EBP sites to other cis elements, specifically the Nkx2.1 binding sites that work synergistically to drive CCSP expression to high baseline levels in adult mouse lung (20) , prompted us to determine whether exposure to hyperoxia affects the binding of C/EBP proteins to the CCSP promoter. The EMSA in Fig. 5A shows a phenomenon of increased protein-DNA interactions with the C/EBP binding site in response to hyperoxia exposure similar to that seen with the AP-1 binding site. The protein-DNA complex in lane 2, formed from nuclear extracts of mtCC exposed to room air and the C/EBP consensus sequence, was significantly reduced compared with the protein-DNA complex in lane 3, formed from nuclear extracts of mtCC exposed to hyperoxia and the C/EBP consensus sequence.
Protein-DNA complexes formed with the C/EBP consensus sequence appeared to migrate as more than a single protein complex. The specificity of protein-DNA interactions with the C/EBP sequence was verified by addition of specific unlabeled oligonucleotides in lane 4 and nonspecific unlabeled oligonucleotides in lane 5.
Further investigations were done to determine whether individual C/EBP family members were in the protein-DNA complexes formed with the C/EBP consensus site. We added antibodies to the individual C/EBPα, C/EBPβ, and C/EBPδ proteins, shown in lanes 6-8 in Fig. 5A . The addition of the antibody to C/EBPβ with the nuclear extracts exposed to hyperoxia resulted in a supershift of some but not all of the complexes bound by the mtCC nuclear extract (Fig. 5A, lane  7) . This may be due to technical limitations of the supershift analysis, which may have given an incomplete supershift, or to the fact that multiple proteins or protein isoforms may interact with C/EBPβ at the C/EBP consensus site, which may block the antibody from binding C/EBPβ. Previous observations of the post-transcriptional processing of the C/EBPβ gene product led to the production of at least four different C/EBPβ protein isoforms in other tissues of the body. This result prompted us to question whether hyperoxia exposure induced specific C/EBPβ isoform production in the lung.
The specific C/EBPβ isoforms that may be generated from the single gene product vary in their inherent ability to trans-activate target gene expression by binding to the same DNA consensus site. The larger molecular size isoforms include the liver-activating protein (LAP), which enhances the expression of target genes. In contrast, the smaller molecular size isoforms of C/EBPβ include the liver-inhibiting protein (LIP), which cannot activate gene expression but may inhibit activation of target genes by binding to the same DNA consensus site. Loss of the trans-activation capacity of the smaller molecular size isoforms is secondary to the lack of the Nterminal DNA activation domain, which may thereby permit LIP to function in a dominant negative manner. Therefore, to determine which C/EBPβ isoforms were altered in hyperoxia exposure, we performed Western blot analyses with mtCC whole cell extracts exposed to 0, 6, 12, or 24 h of hyperoxia. Figure 5B shows that the C/EBPβ isoform LAP was present in mtCC at all time points and that the expression of LIP increased as a function of time in hyperoxia. Western analyses of whole lung homogenates of adult mice exposed to 0, 24, 48, or 72 h demonstrated an increase in expression of both LAP and LIP as a function of time in hyperoxia (data not shown). Transient transfection analyses in mtCC were done to further elucidate the effects of LIP expression on the expression of the 166-bp CCSP-Luc gene in vitro. The cotransfection of a LIP expression vector with the 166-bp CCSP-Luc reporter gene resulted in a dose-dependent decrease in CCSP expression (Fig. 5C) . Cotransfection of an LAP expression vector with the 166-bp CCSP-Luc reporter gene increased CCSP expression above the baseline expression of CCSP, whereas cotransfection of LIP with LAP and the 166-bp CCSP-Luc reporter gene resulted in an attenuation of the gene activation seen with LAP and the 166-bp CCSP-Luc reporter gene alone (data not shown). Together these results suggest that multiple proteins or protein isoforms may interact at the C/EBP consensus site. In the presence of hyperoxia, the LIP C/EBPβ isoform expression is increased in the lung and may act in a dominant negative manner to diminish CCSP gene expression.
Effects of hyperoxia exposure on Nkx2.1 binding to the CCSP promoter
Nkx2.1 is a known enhancer of CCSP expression and was recently shown to act synergistically with C/EBPα to mediate CCSP expression (20) . Therefore, we used EMSA to determine the effects of hyperoxia exposure on Nkx2.1 protein-DNA interactions by nuclear proteins extracted from mtCC exposed to either room air or 95% oxygen for 24 h. The results of these EMSA and supershift analyses are illustrated in Fig. 6A . In lane 2, the nuclear proteins from mtCC cells exposed only to room air formed a DNA-protein complex with the labeled Nkx2.1 probe. However, after 24 h of hyperoxia exposure, the complex of nuclear proteins interacting with the Nkx2.1 probe was dramatically reduced (lane 3). The addition of the specific unlabeled Nkx2.1 oligonucleotide (lane 4) demonstrated the specificity of the protein-DNA interactions and was further verified in lane 5 with the addition of nonspecific unlabeled oligonucleotide. The presence of the Nkx2.1 protein within the protein-DNA complex formed was confirmed in lane 6 with a supershift of a band after addition of an antibody specific for Nkx2.1, but not secondary to the addition of a nonspecific antibody in lane 7. Although the supershift was not complete because of the limitations of the antibody used in the assay, this result does confirm that the protein binding the DNA probe was NKx2.1.
The reduced DNA binding of Nkx2.1 shown by EMSA prompted further investigations to determine whether hyperoxia induced a decrease in total cellular Nkx2.1 content or perhaps just a decrease in nuclear Nkx2.1. The propensity for cytoplasmic trapping of Nkx2.1 was previously reported for H441 and A549 cells after exposure to 12-O-tetradecanoylphorbol-13-acetate (22) . Therefore, immunohistochemistry was done with adult mouse lungs after either 0 h (Fig. 6B ) or 72 h (Fig. 6C ) of hyperoxia exposure to determine the temporal expression pattern of Nkx2.1 protein within the bronchiolar epithelium in vivo. Figure 6B reveals the confined nuclear localization of Nkx2.1 in the bronchiolar epithelium of adult mouse lung exposed to room air. Figure 6C illustrates a more diffuse immunostaining pattern of Nkx2.1 in the bronchiolar epithelium of adult mouse lung exposed to 72 h of hyperoxia, consistent with a shift toward a more cytoplasmic distribution. Western blot analysis shown in Fig. 6D indicated no difference in total cellular Nkx2.1 protein obtained from mtCC exposed to room air or hyperoxia. However, far less immunoreactive protein was present in nuclear extracts of mtCC exposed to hyperoxia than that observed in mtCC exposed only to room air. These results suggest that cytoplasmic sequestration of the Nkx2.1 protein occurs in response to hyperoxia exposure both in vivo and in vitro.
DISCUSSION
Many lung diseases are treated with the administration of supplemental oxygen, although prolonged exposure to high concentrations of oxygen may harm the lung. The subsequent disturbance in the lung secondary to hyperoxia exposure leads to lung inflammation and edema, which culminates in death. The immunohistochemistry in Fig. 2B and 2D illustrates an apparent loss of Clara cell volume after 72 h of hyperoxia, which at this point is presumably secondary secretion of CCSP into the airways and a decrease in ongoing synthesis of CCSP. Although it has been suggested that Clara cells may undergo proliferation and migration into the terminal acini after bleomycin-induced pulmonary fibrosis (23) , there is no evidence of CCSPimmunopositive cells within the distal acini after hyperoxia-induced lung injury. In contrast, the immunohistochemistry does illustrate a reduction in the apparent number of Clara cells lining the distal airways that continued to express CCSP, which was reported in bleomycin-induced pulmonary disease (24) . These results support the hypothesis that Clara cells and potentially CCSP may have a role in epithelial repair and fibrosis.
The findings of the current investigation suggest that hyperoxia-induced repression of CCSP gene expression was regulated by a shift in both composition and localization of the trans-acting factors that bind to the proximal promoter region of the CCSP gene. This shift, in the transcriptionally active protein complex interacting with the CCSP gene, was mediated by two mechanisms involving three families of proteins. The first mechanism involved an increase in the binding of transcriptionally active proteins to cis elements overlapping the HNF-3 binding site, specifically the AP-1 and the C/EBP binding sites. The second mechanism further altered the composition of the transcriptional complex with the loss of nuclear Nkx2.1, a known transcriptional activator, by cytoplasmic sequestration. The activation potential of the hyperoxiainduced transcriptional complex was less than that of the transcriptional complex present in room air exposure.
Observing increased binding of mtCC nuclear proteins to the AP-1 site in the CCSP proximal promoter was not altogether unexpected. Oxidant stress is known to induce the transcriptional activity of AP-1 family members that mediate the induction of other genes in the lung (9) . Despite the fact that each member of the AP-1 family will bind the same DNA consensus sequence, the transcriptional activity varies considerably among specific members of the AP-1 family (25) . Moreover, expression of specific AP-1 family members varies considerably among body tissues. Interestingly, c-Jun expression is proportionally higher in the lung relative to other tissues in the body (26) , and the expression of c-Jun itself is highly inducible by oxidant stress (27) . Therefore, finding that c-Jun was a major constituent of the AP-1 complex binding the CCSP promoter in hyperoxia suggests a potential role specifically for c-Jun in regulating lungspecific proteins in response to oxidant stress. Further support for a role of c-Jun in regulation of lung-specific proteins such as CCSP was provided by the confirmation of a dose-dependent response of CCSP gene expression to c-Jun in cell culture.
The discovery that C/EBPβ protein bound to the CCSP gene and that its binding was increased by hyperoxia exposure was unforeseen. Although C/EBPβ is known to modulate liver-specific genes, its role in the regulation of lung-specific proteins has gone unrecognized. C/EBPβ protein is a transcriptionally active protein that belongs to a family of C/EBP proteins in which two other members, C/EBPα and C/EBPδ, are well known to interact with the CCSP proximal promoter (11) . Therefore, the supershift of only a small component of the specific protein-DNA interactions occurring at the C/EBP consensus sequences suggests that there may be more than a single protein interacting with this site. Indeed, previous evidence would suggest that there may be a combination of proteins (11) , which may include a combination of different C/EBPβ homodimers or heterodimers, or even a combination of C/EBP different family members interacting together. Although the smallest protein-DNA complex was supershifted in the EMSA (Fig. 5A) , it is impossible with the current evidence to determine which individual isoforms of C/EBPβ the antibody is binding with. In view of the visual excess of LAP present in the mtCC cells (Fig. 5B) , one would anticipate that LAP would be involved in most, if not all, the protein-DNA complexes formed with the C/EBP consensus site.
The C/EBP family of proteins, similar to the AP-1 family, functions by forming homodimers or heterodimers that can bind the same C/EBP binding sites. Interestingly, the C/EBPβ intronless gene can produce four different molecular size isoforms by alternative translation or specific proteolytic cleavage of full-length C/EBPβ (28) . The four C/EBPβ isoforms include the fulllength (38-kDa) isoform, a 35-kDa LAP isoform, a 21-kDa LIP isoform, and a 14-kDa isoform. The smaller molecular size isoforms are a result of truncation of the N terminus. This truncation results in a progressive loss of the trans-activation domain of these proteins, thereby leaving the 21-and 14-kDa isoforms unable to activate gene transcription (28, 29) . There is evidence however, that the 21-and 14-kDa isoforms can function as dominant negative inhibitors of C/EBP-mediated gene activity (28, 29) . Although the levels of C/EBPβ LIP expression in hyperoxia-exposed mtCC by Western blot analyses are low compared with the levels of LAP, the inhibition of LAP by LIP occurs with a stoichiometry as low as 5:1. Therefore, induction of LIP may contribute to the decreased CCSP gene expression. Further support for the hypothesis that the LIP C/EBPβ isoform inhibits the expression of the CCSP gene is evident by the dosedependent decrease in CCSP reporter gene activity with the addition of increasing concentrations of a LIP C/EBPβ expression vector in vitro.
The second mechanism driving the decrease of CCSP gene expression in the presence of hyperoxia is the decreased protein-DNA interactions (Fig. 6A ) and the observed shift toward cytoplasmic sequestration of Nkx2.1 (Fig. 6B, 6C, and 6D) . The minor supershift observed in the EMSA suggests the potential for more than a single protein interacting within the protein-DNA complex interacting with the Nkx2.1 consensus site. This premise of multiple proteins present in the protein-DNA complex is supported by previous evidence, which illustrated Nkx2.1 directly interacting with C/EBPα in a synergistic manner to enhance CCSP expression (20) . This strong transcriptional activator is a homeodomain-containing phosphoprotein belonging to the Nkx family (30) . Nkx2.1 is expressed throughout the respiratory epithelium and is critical to lung development, as well as the expression of lung cell-specific proteins (31, 32) . The potential for cytoplasmic sequestration of Nkx2.1 as a mechanism for the regulation of lung-specific proteins was first noted in the regulation of surfactant protein B in A549 cells secondary to exposure to phorbol esters (33) . The cytoplasmic sequestration of Nkx2.1 in Clara cells may precipitate a significant decrease in CCSP gene expression through the loss of protein-DNA interactions at the multiple Nkx2.1 cis elements or the loss of synergistic activity of transcriptionally active proteins, or both. Protein binding at the five known cis elements in the 5'-flanking region of the CCSP gene led to a progressive increase in CCSP expression (12, 17) . Therefore, a loss of nuclear Nkx2.1 protein would account for the hyperoxia responsiveness of both the distal and the proximal promoter regions. The significantly greater expression level of reporter gene activity generated by the distal promoter region certainly suggests that an unidentified transcriptional enhancer (or enhancers) interacts with this region. However, hyperoxia-induced alterations in the protein-DNA interactions occurring with the proximal promoter region spanning -166 to +1 bp will also affect the expression pattern of the distal promoter region spanning -803 to +1 bp. Thus, one could anticipate that hyperoxia exposure would result in a proportional decrease in the expression of the -803-bp and -166-bp CCSP reporter genes. In addition, the loss of nuclear Nkx2.1 would negate the synergistic activity previously reported between Nkx2.1 and C/EBPα to drive high levels of CCSP expression by the proximal CCSP promoter (20) .
These data support the hypothesis that hyperoxia exposure results in the loss of nuclear Nkx2.1 protein, thereby producing a shift in the composition and localization of the transcriptionally active protein complex on the proximal CCSP promoter. The transcriptional potential of the hyperoxia-induced binding of alterative proteins to the C/EBP and AP-1 binding sites is less than that of proteins binding during baseline expression under normal oxygen tension. These proposed mechanisms for hyperoxia-induced repression of CCSP gene expression are shown schematically in Fig. 7 . Initially, under room air conditions, the transcriptional complex is highly active, with binding of the known transcriptional activators Nkx2.1, C/EBP, and HNF-3 proteins. However, with exposure to hyperoxia, the loss of nuclear Nkx2.1 and the increased binding of the inhibitory, LIP, isoform of C/EBPβ and c-Jun alter the transcriptionally active complex, which results in a diminished trans-activation potential of the protein complex interacting with the CCSP proximal promoter. In an effort to determine the functional significance for the altered interaction of each individual trans-acting factor concurrently, a variety of cotransfections were done. We found that cotransfections of LIP with the transcriptional activator Nkx2.1 and the -66-bp reporter gene in the mtCC illustrated that LIP attenuated the induction of CCSP expression by Nkx2.1 from a 2.5-fold increase to a 1-fold increase (data not shown). In addition, cotransfection of c-Jun with Nkx2.1 and the -166-bp reporter gene in mtCC demonstrated that c-Jun attenuated the induction of CCSP to less than onefold (data not shown). These findings thus support the premise that LIP and, possibly even more so, AP-1 interactions with the CCSP promoter are physiologically relevant, regardless of nuclear Nkx2.1.
These novel observations suggest that hyperoxia-induced decreased CCSP gene expression is mediated, at least in part, at the level of transcription and that multiple mechanisms mediate this decrease. These results suggest a complex mechanism for the gene-specific regulation of lung proteins in response to oxidant stress. This utilization of common trans-acting factors interacting with multipartite nucleotide sequences may represent a common physiological mechanism for the tight control of multiple tissue-specific genes in response to common environmental stresses, such as hyperoxia exposure. Moreover, these insights may facilitate the generation of new therapeutic interventions for the preservation of CCSP gene expression, which may reduce the severity of lung injury associated with the clinical use of supplemental oxygen. 4-7) or 95% oxygen (lane 3) and probed with 32 P-labeled oligonucleotides (lanes 1-7) , in the presence of 10-fold excess of specific competitor (lane 4), in the presence of 10-fold excess of nonspecific competitor (lane 5), in the presence of an antibody specific for Nkx2.1 protein (lane 6), or in the presence of a nonspecific antibody (lane 7). Lane 1 shows the result for probe alone. Representative immunohistochemistry for Nkx2.1 protein present in lung tissue obtained from mice after exposure to either 0 h (B) or 72 h (C) of hyperoxic conditions. Scale bars = 50 µm. The long arrows point to confined nuclear staining of Nkx2.1 in lung exposed to room air (B) and to cytoplasmic Nkx2.1 staining in lung exposed to hyperoxia (C). The short arrows point to type II cells, which also demonstrate nuclear Nkx2.1 staining in room air (B) and cytoplasmic Nkx2.1 staining after hyperoxia exposure (C). D) Western blot analyses for Nkx2.1 immunoreactive proteins from whole cell protein extracts or nuclear protein extracts obtained from mtCC cells after exposure to either 0 or 24 h of hyperoxic conditions. 
